Myriad Genetics, Inc. has launched a new educational website called "Know More Sooner," aimed at providing detailed information about reproductive and prenatal genetic testing. The site seeks to ...
When you're expecting a baby, you can also expect to have lots of medical tests. Ultrasound imaging, glucose monitoring and other health checks are a routine part of every pregnancy. There are reasons ...
Researchers have developed a non-invasive genetic test that can screen the blood of pregnant individuals to survey all genes from the fetal genome. A team of investigators from Massachusetts General ...
Myriad Genetics, Inc. announced it will present significant research on early prenatal testing at the Society for Maternal-Fetal Medicine Conference. The study, awarded the Dru Carlson Memorial Award, ...
Myriad Genetics (MYGN) has launched a new educational website providing comprehensive information about reproductive and prenatal genetic testing. The “Know More Sooner” website provides the benefits ...
Genetic testing plays an important role in cystic fibrosis screening and diagnosis. It can help determine if a person has cystic fibrosis or carries gene mutations that cause it. Other tests can also ...
Research: A Fulgent lab technician uses a multichannel pipette to dispense a reagent. El Monte-based genetic testing and clinical lab analysis company Fulgent Genetics Inc., which rode the Covid ...
Expecting mothers typically opt for prenatal genetic testing during their first and third trimesters. Performed with a sample of the mother's blood, this test looks for fetal aneuploidy, an abnormal ...
In the past, parents-to-be concerned with the genetic state of their gestating offspring had to test both the mother’s and father’s blood in order to determine what traits the child would likely ...
(MENAFN- GlobeNewsWire - Nasdaq) Globally, NIPT is seeing increasing uptake across hospitals and diagnostic laboratories as demand for safer, early fetal screening rise and prenatal care pathways ...
Hyderabad, Jan. 09, 2026 (GLOBE NEWSWIRE) -- According to Mordor Intelligence, the non-invasive prenatal testing market is valued at USD 3.90 billion in 2025 and estimated to grow from USD 4.42 ...